Diabetes: HbA1c 58 mmol/mol

Indicator

The percentage of patients with diabetes without moderate or severe frailty, on the register, in whom the last IFCC-HbA1c is 58 mmol/mol or less in the preceding 12 months.

Introduction

The proposed new indicator (IND179) covers a subset of the existing QOF
indicator DM007: The percentage of patients with diabetes, on the register, in whom the last IFCC-HbA1c is 59 mmol/mol or less in the preceding 12 months.

Greater focus on people without frailty may help reduce under-treatment and support better control of biomedical targets amongst this group.

This statement covers a new indicator that is part of the NICE menu of indicators for general practice, following the recommendations of the NICE indicator advisory committee in August 2018.

Resource impact

The resource impact of the proposed indicator is unlikely to be significant.

Removing the people with moderate or severe frailty from the indicator will reduce the risk of iatrogenic harm amongst this group which may result in financial savings, while providing more individualised care for people with moderate or severe frailty may impact on workload. Overall costs or savings associated with this indicator are not estimated to be significant.